Acadian Asset Management »

Ocular Therapeutix shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $23k 2.5k 9.07
2016-06-30 $422k 85k 4.95

More positions owned by Acadian Asset Management

NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Stellantis SHS (STLA)
Check Point Software Tech Ord (CHKP)
Logitech Intl S A SHS (LOGI)
Apple (AAPL)
Spotify Technology S A SHS (SPOT)
Meta Platforms Cl A (META)
McKesson Corporation (MCK)
Cardinal Health (CAH)
Reliance Steel & Aluminum (RS)
Marathon Petroleum Corp (MPC)
Booking Holdings (BKNG)

View all positions for Acadian Asset Management

Top funds holding Ocular Therapeutix

Summer Road
VR Adviser
BlackRock
Vanguard Group
Opaleye Management
Logos Global Management
Citadel Advisors
Perceptive Advisors
Geode Capital Management
Octagon Capital Advisors
Deltec Asset Management
Franklin Resources
Dr. Jeffrey R. Jay, M.D.
Morgan Stanley
Nuveen Asset Management

View all funds holding Ocular Therapeutix